In summary, the results of our study show that complete MTAP expression loss occurs in 20–30% of urothelial carcinomas and that MTAP expression loss is restricted to neoplastic urothelium carrying homozygous 9p21 (MTAP) deletions. Here, MTAP is linked to urothelial carcinoma.